Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer

J Neurol. 2019 Dec;266(12):3163-3166. doi: 10.1007/s00415-019-09562-z. Epub 2019 Oct 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Multiple Sclerosis / chemically induced*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab